www.fdanews.com/articles/159794-biolinerx-inks-in-license-agreement-with-israeli-institutions-for-type-1-diabetes-treatment

BioLineRx Inks In-License Agreement with Israeli Institutions for Type 1 Diabetes Treatment

October 25, 2013

BioLineRx has signed agreements with a number of Israeli institutions to develop and market its Type 1 diabetes antibody treatment.
Genetic Engineering & Biotechnology News